When it comes to decentralized clinical trials, explore why sponsors and research sites might need to look more closely at their specific patient cohorts when determining what individuals they truly need.
Explore how an approach to training that carefully targets site and individual weak areas, along with critical protocol procedures, could not only reduce deviations, but also play a key role in reducing overall burdens on research site personnel.
In theory, sponsors should be picking sites that have known patients that fit a protocol’s inclusion/exclusion criteria. But that does not always happen for a variety of reasons. Find out why in the available article.
Protocol deviations can have a detrimental effect on new drug development, adding to costs and time to clinical trials and even putting the acceptability of data generated during a study at risk. This article seeks to determine whether training in individual protocols is adequate, given the frequency with which deviations occur.